These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33119427)

  • 1. Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder.
    Lokkerbol J; Wijnen B; Ruhe HG; Spijker J; Morad A; Schoevers R; de Boer MK; Cuijpers P; Smit F
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1031-1042. PubMed ID: 33119427
    [No Abstract]   [Full Text] [Related]  

  • 2. Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis.
    Wijnen BFM; Thielen FW; Konings S; Feenstra T; Van Der Gaag M; Veling W; De Haan L; Ising H; Hiligsmann M; Evers SMAA; Smit F; Lokkerbol J
    Expert Rev Pharmacoecon Outcomes Res; 2020 Jun; 20(3):269-279. PubMed ID: 31195900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the cost-effectiveness of a healthcare system for depressive disorders by implementing telemedicine: a health economic modeling study.
    Lokkerbol J; Adema D; Cuijpers P; Reynolds CF; Schulz R; Weehuizen R; Smit F
    Am J Geriatr Psychiatry; 2014 Mar; 22(3):253-62. PubMed ID: 23759290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing and testing of a health-economic Markov model to assess the cost-effectiveness of treatments for Bipolar disorder: TiBipoMod.
    Kleijburg A; Lokkerbol J; Regeer EJ; Geerling B; Evers SMAA; Kroon H; Wijnen B
    Front Psychiatry; 2022; 13():1030989. PubMed ID: 36440423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the cost effectiveness of antidepressant treatment in primary care.
    Revicki DA; Brown RE; Palmer W; Bakish D; Rosser WW; Anton SF; Feeny D
    Pharmacoeconomics; 1995 Dec; 8(6):524-40. PubMed ID: 10160081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
    Meuldijk D; Carlier IV; van Vliet IM; van Hemert AM; Zitman FG; van den Akker-van Marle ME
    J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands.
    van Boven JF; Kocks JW; Postma MJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2191-2201. PubMed ID: 27703341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn's disease using real world evidence in Thailand.
    Phisalprapa P; Kositamongkol C; Limsrivilai J; Aniwan S; Charatcharoenwitthaya P; Pisespongsa P; Kitiyakara T; Treepongkaruna S; Chaiyakunapruk N
    J Med Econ; 2020 Nov; 23(11):1302-1310. PubMed ID: 32729347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
    Rattay T; Dumont IP; Heinzow HS; Hutton DW
    Gastroenterology; 2017 Dec; 153(6):1531-1543.e2. PubMed ID: 29074450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of an experience sampling method intervention in depression compared with treatment as usual using data from a randomized controlled trial.
    Simons CJP; Drukker M; Evers S; van Mastrigt GAPG; Höhn P; Kramer I; Peeters F; Delespaul P; Menne-Lothmann C; Hartmann JA; van Os J; Wichers M
    BMC Psychiatry; 2017 Dec; 17(1):415. PubMed ID: 29284448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and testing of a health economic Markov model for treatment of anorexia nervosa.
    Svendsen VG; Lokkerbol J; Danner UN; Jansingh A; Evers SM; Wijnen BF
    Expert Rev Pharmacoecon Outcomes Res; 2022 Dec; 22(8):1243-1251. PubMed ID: 36047856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complaint-Directed Mini-Interventions for Depressive Symptoms: A Health Economic Evaluation of Unguided Web-Based Self-Help Interventions Based on a Randomized Controlled Trial.
    Wijnen BF; Lokman S; Leone S; Evers SM; Smit F
    J Med Internet Res; 2018 Oct; 20(10):e10455. PubMed ID: 30274958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.